Technical Analysis for MRSN - Mersana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 21.57 -4.52% -1.02
MRSN closed down 4.52 percent on Friday, July 10, 2020, on 30 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical MRSN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Bollinger Band Squeeze Range Contraction -4.52%
Inside Day Range Contraction -4.52%
Bollinger Band Squeeze Range Contraction -5.60%
New 52 Week High Strength -5.60%
BB Squeeze Started Range Contraction -5.60%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mersana Therapeutics, Inc. is a United States-based biotechnology company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs). The Company focuses on advancing a pipeline of targeted oncology therapeutics leveraging its Fleximer immunoconjugate technology. The Fleximer platform allows it to design ADCs with specific properties and manage the drug's chances of attacking cancers. Its product candidates include XMT-1522 and XMT-1536. The ADC therapies treat cancer patients by engineering a drug conjugate with various anti-cancer agents and controlling when, where and how those agents are released. Dolaflexin is its Fleximer antibody drug conjugation platform, which pairs the Fleximer polymer with its linker chemistries to create ADC therapies. XMT-1522 is based on its Dolaflexin platform and has over 15 auristatin molecules per antibody. XMT-1522 is in Phase I clinical trial for various indications of cancers. XMT-1536 is in pre-clinical development.
Medicine Biotechnology Cancer Immunology Cancers Monoclonal Antibodies Chemotherapy Antibody Drug Conjugates Adc Synaffix

Is MRSN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.97
52 Week Low 1.32
Average Volume 2,260,579
200-Day Moving Average 8.22
50-Day Moving Average 17.10
20-Day Moving Average 21.84
10-Day Moving Average 22.54
Average True Range 1.86
ADX 44.83
+DI 24.68
-DI 12.46
Chandelier Exit (Long, 3 ATRs ) 19.38
Chandelier Exit (Short, 3 ATRs ) 24.39
Upper Bollinger Band 23.84
Lower Bollinger Band 19.85
Percent B (%b) 0.43
BandWidth 18.27
MACD Line 1.39
MACD Signal Line 1.74
MACD Histogram -0.3485
Fundamentals Value
Market Cap 489.92 Million
Num Shares 22.7 Million
EPS -16.23
Price-to-Earnings (P/E) Ratio -1.33
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.93
Resistance 3 (R3) 24.09 23.47 23.54
Resistance 2 (R2) 23.47 22.86 23.39 23.41
Resistance 1 (R1) 22.52 22.49 22.21 22.36 23.28
Pivot Point 21.89 21.89 21.74 21.81 21.89
Support 1 (S1) 20.94 21.29 20.63 20.78 19.86
Support 2 (S2) 20.32 20.92 20.24 19.73
Support 3 (S3) 19.37 20.32 19.60
Support 4 (S4) 19.21